Cargando…

Potential intravenous immunoglobulin-induced optic disc edema

PURPOSE: To report a case of recurrent and bilateral optic disc edema following intravenous immunoglobulin (IVIG) administration. OBSERVATIONS: A 46 year-old woman received IVIG on 3 separate occasions over 7 years for Non-Hodgkin's Lymphoma (NHL) and each time developed headaches and transient...

Descripción completa

Detalles Bibliográficos
Autores principales: Britton, Anna K., Vaze, Anagha, Milliken, Sam, Fraser, Clare L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249594/
https://www.ncbi.nlm.nih.gov/pubmed/35789798
http://dx.doi.org/10.1016/j.ajoc.2022.101617
_version_ 1784739617615904768
author Britton, Anna K.
Vaze, Anagha
Milliken, Sam
Fraser, Clare L.
author_facet Britton, Anna K.
Vaze, Anagha
Milliken, Sam
Fraser, Clare L.
author_sort Britton, Anna K.
collection PubMed
description PURPOSE: To report a case of recurrent and bilateral optic disc edema following intravenous immunoglobulin (IVIG) administration. OBSERVATIONS: A 46 year-old woman received IVIG on 3 separate occasions over 7 years for Non-Hodgkin's Lymphoma (NHL) and each time developed headaches and transient visual disturbance, and was subsequently found to have bilateral optic disc swelling. Lumbar puncture confirmed raised cerebrospinal fluid (CSF) opening pressure and there was resolution following treatment with oral acetazolamide (Diamox). CONCLUSIONS AND IMPORTANCE: To our knowledge there is no literature on papilledema following administration of IVIG. This case is pertinent for physicians treating patients with IVIG who develop headache, transient visual disturbance and optic disc edema.
format Online
Article
Text
id pubmed-9249594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92495942022-07-03 Potential intravenous immunoglobulin-induced optic disc edema Britton, Anna K. Vaze, Anagha Milliken, Sam Fraser, Clare L. Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of recurrent and bilateral optic disc edema following intravenous immunoglobulin (IVIG) administration. OBSERVATIONS: A 46 year-old woman received IVIG on 3 separate occasions over 7 years for Non-Hodgkin's Lymphoma (NHL) and each time developed headaches and transient visual disturbance, and was subsequently found to have bilateral optic disc swelling. Lumbar puncture confirmed raised cerebrospinal fluid (CSF) opening pressure and there was resolution following treatment with oral acetazolamide (Diamox). CONCLUSIONS AND IMPORTANCE: To our knowledge there is no literature on papilledema following administration of IVIG. This case is pertinent for physicians treating patients with IVIG who develop headache, transient visual disturbance and optic disc edema. Elsevier 2022-06-16 /pmc/articles/PMC9249594/ /pubmed/35789798 http://dx.doi.org/10.1016/j.ajoc.2022.101617 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Britton, Anna K.
Vaze, Anagha
Milliken, Sam
Fraser, Clare L.
Potential intravenous immunoglobulin-induced optic disc edema
title Potential intravenous immunoglobulin-induced optic disc edema
title_full Potential intravenous immunoglobulin-induced optic disc edema
title_fullStr Potential intravenous immunoglobulin-induced optic disc edema
title_full_unstemmed Potential intravenous immunoglobulin-induced optic disc edema
title_short Potential intravenous immunoglobulin-induced optic disc edema
title_sort potential intravenous immunoglobulin-induced optic disc edema
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249594/
https://www.ncbi.nlm.nih.gov/pubmed/35789798
http://dx.doi.org/10.1016/j.ajoc.2022.101617
work_keys_str_mv AT brittonannak potentialintravenousimmunoglobulininducedopticdiscedema
AT vazeanagha potentialintravenousimmunoglobulininducedopticdiscedema
AT millikensam potentialintravenousimmunoglobulininducedopticdiscedema
AT fraserclarel potentialintravenousimmunoglobulininducedopticdiscedema